GlaxoSmithKline Consumer Nigeria Plc. manufacture, markets and distributes healthcare products. A global pharmaceutical giant, one of Africa’s largest consumer and healthcare companies is also the biggest drug maker in the UK
Incorporated in 1971, the Company which was listed on the Nigerian Stock Exchange on July 1979 has a mission to improve the quality of human life by enabling people to do more, feel better and live longer.
In Nigeria, GlaxoSmithKline has been a dominant and leading force in the healthcare industry, having a strong presence in the country for the past 40 years. GlaxoSmithKline operates globally with business units focused on pharmaceuticals, vaccines and consumer healthcare products. The Nigerian operations engaged in the manufacture, marketing, and distribution of consumer healthcare and pharmaceutical products.
With a mission is to improve the quality of human life by enabling people to do more, feel better and live longer, the company operates in two segments, Pharmaceuticals and Consumer Healthcare. It offers consumer healthcare products, including oral care products, OTC medicines, and nutritional health care products primarily under the Panadol, Andrews Liver Salt, Macleans, Sensodyne, Phensic, Lucozade, and Ribena brands; and pharmaceutical products comprising prescription drugs and vaccines primarily under the Ampiclox, Amoxil and Augmentin Antibiotics, Zentel, and Halfan brands. GlaxoSmithKline Consumer Nigeria Plc provides its pharmaceutical products for the treatment of asthma, malaria, depression, migraine, diabetes, heart failure, digestive conditions, and cancer; and vaccines to protect against illnesses, such as hepatitis A and B, diphtheria, tetanus, whooping cough, typhoid, influenza, and cervical cancer. The company was formerly known as Beecham Limited. GlaxoSmithKline Consumer Nigeria Plc is a subsidiary of GlaxoSmithKline Plc, United Kingdom.
GlaxoSmithKline Nigeria is committed to putting value back into the communities in which it operates. The company, over the years has been investing in various community partnership projects aimed at not only increasing community access to healthcare, but also at empowering communities at the grassroots level. All GSK projects are developed in partnership with not only the authorities and appropriate NGOs concerned but especially the communities to which such projects belong.
